The S118 site of YY1 showed higher phosphorylation levels in breast cancer, colon cancer, UCEC, and LUAD tumor tissues (all P < 0.05) and showed lower phosphorylation levels in ovarian and clear cell carcinomas (both P < 0.05). Here, YY1 is linked to neoplasm.